Anti-seizure Medications 💊
Reference table of anti-seizure medications: levetiracetam (Keppra), valproate (Epilim), lamotrigine, carbamazepine, phenytoin, lacosamide and clobazam. Irish SmPC doses, IV options when nil by mouth, and key interactions.
💡 On the ward
- Never stop or skip an anti-seizure medication without a neurology plan.
- Missed dose: give it now unless the next dose is due within a few hours.
- Nil by mouth: levetiracetam, valproate and lacosamide have IV forms at the same dose. Others: NG liquid or dispersible, or ask pharmacy.
- Keep the same brand for carbamazepine and phenytoin.
- Actively seizing: see Seizure.
Anti-seizure medications (adult)
Levetiracetam (Keppra)
- Route
- PO / IV
- Dose
- 250–500 mg to start, up to 1.5 g
- Frequency
- BD
- Notes
- IV dose = PO dose. Reduce if CrCl <80. Mood change, irritability
Sodium valproate (Epilim)
- Route
- PO / IV
- Dose
- 600 mg/day to start, usual 1–2 g/day
- Frequency
- BD
- Notes
- Max 2.5 g/day. IV = PO. Prevent programme in women. Liver, pancreatitis
Lamotrigine (Lamictal)
- Route
- PO
- Dose
- 25 mg to start, usual 100–200 mg/day
- Frequency
- OD or BD
- Notes
- Slow titration: SJS/TEN risk. With valproate: start 12.5 mg. With enzyme inducers: higher doses. No IV
Carbamazepine (Tegretol)
- Route
- PO
- Dose
- 100–200 mg to start, usual 0.8–1.2 g/day
- Frequency
- Divided, BD–QDS
- Notes
- Max usually 1.2 g/day. Hyponatraemia. Enzyme inducer. SJS/TEN: HLA-B*1502 if Han Chinese or Thai
Phenytoin (Epanutin)
- Route
- PO / IV
- Dose
- 3–4 mg/kg/day, usual 200–500 mg/day
- Frequency
- OD or BD
- Notes
- Narrow range: check trough level. Liquid and capsule doses differ. IV max 50 mg/min with ECG. SJS/TEN
Lacosamide (Vimpat)
- Route
- PO / IV
- Dose
- 50 mg to start, usual 100–200 mg
- Frequency
- BD
- Notes
- IV = PO. PR prolongation: ECG if cardiac disease. Max 250 mg/day if CrCl ≤30
Clobazam (Frisium)
- Route
- PO
- Dose
- 10–20 mg/day to start
- Frequency
- OD nocte or BD
- Notes
- Adjunct. Increase by 10 mg, max 60 mg/day. Sedation, tolerance
| Drug | Route | Dose | Frequency | Notes |
|---|---|---|---|---|
| Levetiracetam (Keppra) | PO / IV | 250–500 mg to start, up to 1.5 g | BD | IV dose = PO dose. Reduce if CrCl <80. Mood change, irritability |
| Sodium valproate (Epilim) | PO / IV | 600 mg/day to start, usual 1–2 g/day | BD | Max 2.5 g/day. IV = PO. Prevent programme in women. Liver, pancreatitis |
| Lamotrigine (Lamictal) | PO | 25 mg to start, usual 100–200 mg/day | OD or BD | Slow titration: SJS/TEN risk. With valproate: start 12.5 mg. With enzyme inducers: higher doses. No IV |
| Carbamazepine (Tegretol) | PO | 100–200 mg to start, usual 0.8–1.2 g/day | Divided, BD–QDS | Max usually 1.2 g/day. Hyponatraemia. Enzyme inducer. SJS/TEN: HLA-B*1502 if Han Chinese or Thai |
| Phenytoin (Epanutin) | PO / IV | 3–4 mg/kg/day, usual 200–500 mg/day | OD or BD | Narrow range: check trough level. Liquid and capsule doses differ. IV max 50 mg/min with ECG. SJS/TEN |
| Lacosamide (Vimpat) | PO / IV | 50 mg to start, usual 100–200 mg | BD | IV = PO. PR prolongation: ECG if cardiac disease. Max 250 mg/day if CrCl ≤30 |
| Clobazam (Frisium) | PO | 10–20 mg/day to start | OD nocte or BD | Adjunct. Increase by 10 mg, max 60 mg/day. Sedation, tolerance |
⚠️ Cautions
- Valproate: not for women or girls who could get pregnant, unless other drugs failed and on the Prevent programme. LFTs in first 6 months; ammonia if confused.
- Carbapenems (meropenem) drop valproate levels within two days. Avoid together.
- Carbamazepine and phenytoin lower warfarin, DOAC, steroid and contraceptive levels.
- New rash on lamotrigine, carbamazepine or phenytoin, especially in the first 8 weeks: think SJS/TEN. Stop and get senior review.
- Lamotrigine stopped for about a week or more: re-titrate.
- Phenytoin level: interpret with caution if albumin is low. Other levels only if toxicity or adherence query.
- Check sodium on carbamazepine and oxcarbazepine.
Related NICE guidance
NICENICE NG217 — Epilepsies in children, young people and adults
Full guidance on nice.org.uk. BetterCall is not endorsed by NICE.
Educational reference only. Medical disclaimer